LHC Group (NASDAQ:LHCG) Given Hold Rating at Robert W. Baird

Robert W. Baird reaffirmed their hold rating on shares of LHC Group (NASDAQ:LHCG) in a report published on Friday, November 10th. The firm currently has a $69.00 price objective on the health services provider’s stock.

Other equities analysts also recently issued research reports about the stock. Royal Bank Of Canada reissued a buy rating and issued a $70.00 target price on shares of LHC Group in a report on Wednesday, September 6th. BidaskClub raised shares of LHC Group from a hold rating to a buy rating in a report on Friday, August 18th. Zacks Investment Research raised shares of LHC Group from a hold rating to a buy rating and set a $67.00 target price on the stock in a report on Saturday, August 5th. Jefferies Group reissued a buy rating and issued a $68.00 target price on shares of LHC Group in a report on Friday, August 4th. Finally, Craig Hallum reaffirmed a buy rating and set a $80.00 price target (up previously from $67.00) on shares of LHC Group in a research note on Tuesday, November 7th. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock presently has an average rating of Buy and an average target price of $77.10.

LHC Group (NASDAQ:LHCG) traded up $0.50 during mid-day trading on Friday, hitting $66.51. 296,300 shares of the stock traded hands, compared to its average volume of 144,553. LHC Group has a 1 year low of $41.66 and a 1 year high of $76.14. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a market capitalization of $1,282.82, a P/E ratio of 30.12, a PEG ratio of 2.08 and a beta of 0.70.

LHC Group (NASDAQ:LHCG) last released its earnings results on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, topping the consensus estimate of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The firm had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. During the same quarter in the previous year, the firm earned $0.54 earnings per share. The company’s quarterly revenue was up 18.2% compared to the same quarter last year. equities analysts expect that LHC Group will post 2.4 EPS for the current fiscal year.

In related news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the sale, the chief operating officer now owns 109,235 shares of the company’s stock, valued at $7,137,414.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 14.80% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently made changes to their positions in LHCG. BlackRock Inc. raised its stake in shares of LHC Group by 43,223.7% in the first quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after acquiring an additional 1,964,950 shares during the period. Royal Bank of Canada raised its stake in shares of LHC Group by 50,943.5% in the second quarter. Royal Bank of Canada now owns 165,381 shares of the health services provider’s stock valued at $11,229,000 after acquiring an additional 165,057 shares during the period. Castleark Management LLC purchased a new stake in shares of LHC Group in the second quarter valued at $7,661,000. AJO LP purchased a new stake in shares of LHC Group in the second quarter valued at $6,300,000. Finally, Robeco Institutional Asset Management B.V. purchased a new stake in shares of LHC Group in the third quarter valued at $5,197,000. 85.25% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “LHC Group (NASDAQ:LHCG) Given Hold Rating at Robert W. Baird” was originally posted by BBNS and is owned by of BBNS. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://baseballnewssource.com/markets/lhc-group-lhcg-earns-hold-rating-from-robert-w-baird/1773852.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.